Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season. - Wikidata - wikimedia - TriplyDB

Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season.

Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season.

http://www.wikidata.org/entity/Q37164761

about

Systematic review of influenza resistance to the neuraminidase inhibitors Impact of the H275Y and I223V Mutations in the Neuraminidase of the 2009 Pandemic Influenza Virus In Vitro and Evaluating Experimental Reproducibility Clinical Implications of Antiviral Resistance in Influenza Influenza treatment and prophylaxis with neuraminidase inhibitors: a review Recent progress in structure-based anti-influenza drug design Hedging against antiviral resistance during the next influenza pandemic using small stockpiles of an alternative chemotherapy Prolonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferrets Cloned defective interfering influenza virus protects ferrets from pandemic 2009 influenza A virus and allows protective immunity to be established Structural and Functional Basis of Resistance to Neuraminidase Inhibitors of Influenza B Viruses H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural Analysis A Novel I221L Substitution in Neuraminidase Confers High-Level Resistance to Oseltamivir in Influenza B Viruses Synthesis, structure and inhibitory activity of a stereoisomer of oseltamivir carboxylate Influenza virus inactivation for studies of antigenicity and phenotypic neuraminidase inhibitor resistance profiling Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance Enhanced mammalian transmissibility of seasonal influenza A/H1N1 viruses encoding an oseltamivir-resistant neuraminidase Oseltamivir-resistant pandemic H1N1/2009 influenza virus possesses lower transmissibility and fitness in ferrets Environmental levels of the antiviral oseltamivir induce development of resistance mutation H274Y in influenza A/H1N1 virus in mallards A mathematical framework for estimating pathogen transmission fitness and inoculum size using data from a competitive mixtures animal model Simultaneous detection of oseltamivir- and amantadine-resistant influenza by oligonucleotide microarray visualization I222 Neuraminidase mutations further reduce oseltamivir susceptibility of Indonesian Clade 2.1 highly pathogenic Avian Influenza A(H5N1) viruses Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective Oseltamivir (Tamiflu(®)) in the environment, resistance development in influenza A viruses of dabbling ducks and the risk of transmission of an oseltamivir-resistant virus to humans - a review The Emergence of Oseltamivir-Resistant Seasonal Influenza A (H1N1) Virus in Korea During the 2008-2009 Season.Drug resistance in influenza A virus: the epidemiology and management.The pharmacological management of severe influenza infection - 'existing and emerging therapies'.Tracking oseltamivir-resistance in New Zealand influenza viruses during a medicine reclassification in 2007, a resistant-virus importation in 2008 and the 2009 pandemic.Comparative dynamics and distribution of influenza drug resistance acquisition to protein m2 and neuraminidase inhibitors.In vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virus.Synergistic combinations of favipiravir and oseltamivir against wild-type pandemic and oseltamivir-resistant influenza A virus infections in mice.Continuing challenges in influenza.Q&A: What have we found out about the influenza A (H1N1) 2009 pandemic virus?Emergence of H5N1 avian influenza viruses with reduced sensitivity to neuraminidase inhibitors and novel reassortants in Lao People's Democratic Republic.Drug Repurposing Identifies Inhibitors of Oseltamivir-Resistant Influenza Viruses Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients.Genetic characterization of the influenza A pandemic (H1N1) 2009 virus isolates from India.In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses.Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays.Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia.Drugs in development for influenza.

P2860

Q21261835-2E0B3C94-1EF6-4143-9FD2-86687A2BC604 Q24288661-623F6612-D624-493D-9E2A-394EFD46031F Q26782746-21E6D46E-DCF1-4207-82AB-43F8FFCEA4AC Q26860032-AB35309F-A2A1-4F54-B770-A7C666186E5B Q26863710-210AD00D-FB3F-48ED-846B-EE537FBD4F56 Q27307203-4D630C83-8FFA-44B3-8D46-942D9FFD434B Q27334946-52342485-FB30-4FA9-B229-427A58D4A74A Q27336337-ADCB8D1D-AC28-4C93-82A0-7D1D357AEE5E Q27663966-1CCFA2D2-9F7E-4812-862E-A717EB1C51FA Q27673887-B1C8F5BF-ED75-4681-9A0A-2EF08F3D0CF0 Q27683640-15C2EB19-B4E6-48D3-BF7B-B541623A45FB Q27688897-E516364A-C16B-4A62-B2BF-F1E1226FB831 Q28270978-27C4B029-C96F-441A-87C4-ECC50BF93DB3 Q28282405-58580C73-2253-4F01-91CF-1789A9F17FCA Q28387364-BF12886D-55AD-43DC-B637-C4EDA4885B40 Q28474960-ECF498A5-8854-4BA4-ABF3-F9D33ED83907 Q28477046-1AB2C138-0C9A-4F86-AEAB-63ECCA8B3DAB Q28477927-DB017C9C-FB48-422D-BE1D-6F9F28E2E8FF Q28486551-AF7D0895-86A2-4914-A2C9-FA4AF17EF6DD Q28533778-2B3641E5-EB50-464A-A1BF-9D8BBC660A95 Q28541953-ECAAD8D1-4F7C-49E9-833B-22FC6A0FF72D Q28740919-7D1A89B6-A9D6-40E7-8A64-70B2933B0290 Q30224096-B85A1045-FE67-41CB-9CF8-D9D41C3CE6DB Q30224872-239560C6-7933-4A59-B039-E65489F50F3B Q30234600-A75E3579-4F1A-4CEE-B137-4E0DFAA999A0 Q30243907-25C9BEFB-6F62-494A-925B-72D407F3B098 Q30352557-7A42C662-4BB4-4C54-AFE6-871FA82C07E0 Q30355434-54446DED-2FA0-4E6F-9077-4C3144F88434 Q30356466-451F073B-F2E1-40F6-942F-FC38925DC8E8 Q30359363-CD9E9066-D218-4C84-9C99-F91F4008D029 Q30363190-E7D63885-C34E-4CE7-948C-73A9FBF070B8 Q30380953-EE700FC7-99FE-430E-9287-E1532F44482E Q30383545-64915AFE-84FA-41D8-BBD5-4EAC8090EAB6 Q30384081-A3025856-7A17-4A4D-9A14-F07D50798DF4 Q30386485-EFB56413-5C42-4CAD-879D-EAE5567F5094 Q30387015-2510B7B6-1AE9-40B4-B9C8-F649DCD72D1F Q30387420-CFDB0FAD-D6FE-48DE-A6EE-B11F250E08DE Q30390818-3BA4A232-62CD-41B2-9DD7-EE0BEBD10650 Q30390856-3BA311C5-2620-4018-B06A-B0EF826F489D Q30391218-6E0C1155-9F03-45B2-A078-F4CB9B35AB76

P2860

Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season.

http://www.wikidata.org/entity/Q37164761

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season.

@en

Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season.

@nl

type

label

Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season.

@en

Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season.

@nl

prefLabel

Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season.

@en

Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season.

@nl

P1433

Q37164761-8E8B33B5-B525-4C88-B221-55B3690F7B26

P1476

Q37164761-3753270C-1B07-4C11-A269-953EDCFA948C

P2093

Q37164761-0AB7C8A1-4BAC-4987-B399-9F01FBCADF09

Q37164761-13DED315-977F-4C84-8C96-2349D2046165

Q37164761-341B7504-FFBF-4AEA-8B20-03F94CD932AA

Q37164761-54C872C9-F6FC-4640-9852-18912CC22F51

Q37164761-59A0D675-ADC8-4687-92C2-C74DEB9D6C5E

Q37164761-6A220C40-65AA-438B-8BEA-93B337B5DA59

Q37164761-B1323A63-9AAD-4377-98AF-6BFFE5CD7EBD

Q37164761-C3321550-914A-4AA4-8336-90C164C2502C

Q37164761-E4F5E65E-6634-419E-95E1-9A1340412DC7

Q37164761-EF97E82B-69F5-4772-A1AE-176DD2E1FB39

P2860

Q37164761-104B4ED1-8EAD-44B7-87B8-C319D9B3C5F5

Q37164761-275ABC35-428B-4311-98A3-EE1DCA1866EE

Q37164761-42434378-56D5-4719-A984-FFE82DBD454A

Q37164761-47664923-9CA2-406B-88D0-CE30AF9CD341

Q37164761-48240589-4C4B-4327-A707-39D2B1938C0B

Q37164761-49C09B4A-433B-431B-B61D-0053C97F4CDA

Q37164761-4D124B83-B94F-4440-B2B1-572CA6F13F9C

Q37164761-52BC0B9C-C6B2-4CDC-8820-6DBDFBCF3927

Q37164761-5C59F49E-D384-49FB-A4A7-8643F014F3CC

Q37164761-6026107D-63D5-4FE7-8376-5748CE79D2D0

P304

Q37164761-5C158C53-F198-4BA5-9101-135BDDF9539D

P31

Q37164761-F24500D6-63AC-49ED-B893-369FEC0FEF5F

P356

Q37164761-13A9F804-E940-46D9-A1FC-F23713AB566F

P433

Q37164761-674D7CC5-565F-471D-95F3-4B7554903004

P478

Q37164761-7108EE02-7AB6-40CB-8C17-0D8B4084CA87

P50

Q37164761-2AC2D50D-6A09-4AA7-9840-51D850BC332C

P577

Q37164761-32ED9E02-FE6E-4A41-975E-AFD756FEB467

P5875

Q37164761-F89A1537-200A-4A08-98FB-ACE66473245C

P698

Q37164761-7DDDE34C-53D7-457E-B573-24C6E54FFE07

P932

Q37164761-63D003CE-CF55-41FE-88BC-9B5F4A33B4D6

P356

P1433

Emerging Infectious Diseases

P1476

Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season.

@en

P2093

Adam Meijer

http://www.w3.org/2001/XMLSchema#string

Alan Hay

http://www.w3.org/2001/XMLSchema#string

Angie Lackenby

http://www.w3.org/2001/XMLSchema#string

Brunhilde Schweiger

http://www.w3.org/2001/XMLSchema#string

Bruno Lina

http://www.w3.org/2001/XMLSchema#string

European Influenza Surveillance Scheme

http://www.w3.org/2001/XMLSchema#string

Jan van-de-Kassteele

http://www.w3.org/2001/XMLSchema#string

John Paget

http://www.w3.org/2001/XMLSchema#string

Maria Zambon

http://www.w3.org/2001/XMLSchema#string

Matthias Opp

http://www.w3.org/2001/XMLSchema#string

P2860

The war against influenza: discovery and development of sialidase inhibitors

Implementation of the community network of reference laboratories for human influenza in Europe.

Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic.

Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo.

Influenza antiviral susceptibility monitoring activities in relation to national antiviral stockpiles in Europe during the winter 2006/2007 season.

Rapid quantitation of neuraminidase inhibitor drug resistance in influenza virus quasispecies.

Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use.

Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir.

Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir.

The global impact of influenza on morbidity and mortality

P304

552-560

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3201/EID1504.181280

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24244078

http://www.w3.org/2001/XMLSchema#string

P698

19331731

http://www.w3.org/2001/XMLSchema#string

P932

2671453

http://www.w3.org/2001/XMLSchema#string